T-cell immunotherapy hit headlines last year when British baby Layla Richards became one of the first people in the world to be given the treatment, which is made from the body’s own cells.
Now, two landmark studies have revealed the therapy’s stunning potential. One suggests it will last for at least 14 years in the body, raising the tantalising prospect of a permanent cure for cancer. In the other, 94 per cent of terminally ill patients saw the disease vanish completely. ..read more>>>...
